Dr. Markus Fido

Founder, Managing Director

Dr. Markus Fido has more than 20 years of experience in pharmaceutical industry, with focus in vaccines, recombinant proteins, and immune therapeutics. He has profound expertise in regulatory aspects such as third-party audits, authority inspections and GMP guidelines.

He has a management consulting education and holds a doctorate degree in immunology/biochemistry from the Technical University of Graz, Austria. Markus started his carrier at a Novartis “Spin-off” in Vienna in 2006, later on he has acquired the oncology division from Novartis and founded 2 Biotech companies Vela Labs & Meridian Biopharmaceutics.

Besides serving as a CEO and formal Managing Director, Markus has also taken responsibilities as a Head of Regulatory Affairs within the Quality Operations team.

Markus was previously Head Quality Control at a Novartis Spin-off Biopharma where he was responsible for all QC aspects of pre-clinical and clinical projects such as stability studies, specifications, method validation, and product release.

Before he was Group Leader of Immunology and Product Development at Biomin GmbH, Head Biochemical Control at Baxter AG and Head Quality Operations at Octa pharma AG.

Biomin AG Lab Head, Cell culture lab, development of immune enhancer drugs

Baxter Inc. QC Manager, Quality control of vaccines & coagulation factors

Octapharma AG Head of Quality Operations & Quality Control

Novartis AG Head Quality Control, Oncology, cancer immune therapy, product development of glyco-engineered mAbs

Management Buy-out Vela Labs & Meridian Biopharma Founder & Managing Director of 2 Biotech companies Mfi Bio-Consulting GmbH Founder & CEO, Consultancy & training

Products: Biologics, Biopharmaceuticals, Biosimilars, ATMPs, Monoclonals, Vaccines, Coagulation factors, Plasma products

Focus: Analytics, Quality Control, Quality Assurance, Process & Clinical Development, Regulatory Affairs

Member of advice team for ATMPs (ECA) & EMA Working Group